Arteris, Inc., together with its subsidiaries, provides semiconductor system intellectual property (IP) solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia Pacific, Europe, and the Middle East. It manages on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. The company offers Network-on-Chip (NoC) IP Products, such as FlexGen, FlexNoC, and FlexWay, a non-coherent NoC IP; Ncore, a cache-coherent NoC IP; and CodaCache, a last-level cache. It also provides hardware security verification software products, such as Cycuity Radix-S to detect and remediate security issues in IP blocks and subsystems of an SoC; Cycuity Radix-M for hardware security verification emulation for system-level SoC and firmware; and Cycuity Radix-ST, a static security analyzer that identifies potential design weaknesses early in the development lifecycle, as well as SoC integration automation software solutions products, including Magillem Connectivity and Registers, and CSRCompiler. In addition, the company offers professional services, such as training, design assistance, and consulting; licensing services for software and intellectual properties; IP support and maintenance; and on-site support services. It serves the automotive, communications, enterprise computing, consumer electronics, and industrial markets. Arteris, Inc. was founded in 2003 and is headquartered in Campbell, California.…
Has Arteris (AIP) Stock Run Ahead Of What Sales Support?
Arteris (NASDAQ: AIP) is listed on Nasdaq, where its shares trade in USD. It belongs to the Semiconductors industry, part of the Technology sector, and reports about 373 employees.
The shares were at 16.50 USD on 20 November 2026, up 14.0% over 52 weeks. Its 52-week range is 12.06 USD to 50.26 USD: the price is 67.2% below the high and 36.8% above the low.
Its market capitalisation is 819.35M USD.
Arteris reports return on equity of 237.5%, an operating margin of -40.6% and revenue up 48.1% year over year.
It holds more cash than debt, a net cash position of 95.01M USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 7 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 33.00 USD is 100.0% above the current price. The next earnings report is expected on 9 February 2027.